Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data J Racle, K de Jonge, P Baumgaertner, DE Speiser, D Gfeller elife 6, e26476, 2017 | 967 | 2017 |
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer JL Tanyi, S Bobisse, E Ophir, S Tuyaerts, A Roberti, R Genolet, ... Science translational medicine 10 (436), eaao5931, 2018 | 396 | 2018 |
EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data J Racle, D Gfeller Bioinformatics for cancer immunotherapy: methods and protocols, 233-248, 2020 | 331 | 2020 |
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes J Racle, J Michaux, GA Rockinger, M Arnaud, S Bobisse, C Chong, ... Nature biotechnology 37 (11), 1283-1286, 2019 | 249 | 2019 |
High-throughput and sensitive immunopeptidomics platform reveals profound interferonγ-mediated remodeling of the human leukocyte antigen (HLA) ligandome C Chong, F Marino, HS Pak, J Racle, RT Daniel, M Müller, D Gfeller, ... Molecular & Cellular Proteomics 17 (3), 533-548, 2018 | 198 | 2018 |
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis S Trabanelli, MF Chevalier, A Martinez-Usatorre, A Gomez-Cadena, ... Nature communications 8 (1), 593, 2017 | 197 | 2017 |
ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence MF Chevalier, S Trabanelli, J Racle, B Salomé, V Cesson, D Gharbi, ... The Journal of clinical investigation 127 (8), 2916-2929, 2017 | 194 | 2017 |
Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer S Bobisse, R Genolet, A Roberti, JL Tanyi, J Racle, BJ Stevenson, C Iseli, ... Nature communications 9 (1), 1092, 2018 | 146 | 2018 |
The length distribution and multiple specificity of naturally presented HLA-I ligands D Gfeller, P Guillaume, J Michaux, HS Pak, RT Daniel, J Racle, G Coukos, ... The Journal of Immunology 201 (12), 3705-3716, 2018 | 145 | 2018 |
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment A Newey, B Griffiths, J Michaux, HS Pak, BJ Stevenson, A Woolston, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 115 | 2019 |
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting J Schmidt, AR Smith, M Magnin, J Racle, JR Devlin, S Bobisse, J Cesbron, ... Cell Reports Medicine 2 (2), 2021 | 106 | 2021 |
Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma E Dheilly, E Battistello, N Katanayeva, S Sungalee, J Michaux, G Duns, ... Cancer cell 37 (5), 674-689. e12, 2020 | 82 | 2020 |
A phase Ib study of the combination of personalized autologous dendritic cell vaccine, aspirin, and standard of care adjuvant chemotherapy followed by nivolumab for resected … M Bassani-Sternberg, A Digklia, F Huber, D Wagner, C Sempoux, ... Frontiers in immunology 10, 1832, 2019 | 65 | 2019 |
A novel pulse-chase SILAC strategy measures changes in protein decay and synthesis rates induced by perturbation of proteostasis with an Hsp90 inhibitor I Fierro-Monti, J Racle, C Hernandez, P Waridel, V Hatzimanikatis, ... PLoS One 8 (11), e80423, 2013 | 62 | 2013 |
Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands M Solleder, P Guillaume, J Racle, J Michaux, HS Pak, M Müller, G Coukos, ... Molecular & Cellular Proteomics 19 (2), 390-404, 2020 | 54 | 2020 |
The SIB Swiss Institute of Bioinformatics’ resources: focus on curated databases SIB Swiss Institute of Bioinformatics Members Nucleic acids research 44 (D1), D27-D37, 2016 | 51 | 2016 |
Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy I Fierro-Monti, P Echeverria, J Racle, C Hernandez, D Picard, M Quadroni PLoS One 8 (11), e80425, 2013 | 45 | 2013 |
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2. 2 and PRIME2. 0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes D Gfeller, J Schmidt, G Croce, P Guillaume, S Bobisse, R Genolet, ... Cell Systems 14 (1), 72-83. e5, 2023 | 34 | 2023 |
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes J Racle, P Guillaume, J Schmidt, J Michaux, A Larabi, K Lau, MAS Perez, ... Immunity 56 (6), 1359-1375. e13, 2023 | 28 | 2023 |
A Genome-Scale Integration and Analysis of Lactococcus lactis Translation Data J Racle, F Picard, L Girbal, M Cocaign-Bousquet, V Hatzimanikatis PLoS computational biology 9 (10), e1003240, 2013 | 28 | 2013 |